Drug Type Small molecule drug |
Synonyms 2-(2-Methyl-5-nitroimidazol-1-yl)ethyl benzoate, Benzoyl metronidazole, Benzoylmetronidazole + [3] |
Target- |
Mechanism DNA synthesis inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization- |
Active Organization- |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date CN (26 Nov 2002), |
Regulation- |
Molecular FormulaC13H13N3O4 |
InChIKeyCUUCCLJJOWSASK-UHFFFAOYSA-N |
CAS Registry13182-89-3 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D08214 | Metronidazole Benzoate | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Amebiasis | CN | - | 26 Nov 2002 |
Anaerobic bacterial infection | CN | - | 26 Nov 2002 |
Balantidiasis | CN | - | 26 Nov 2002 |
Dracunculiasis | CN | - | 26 Nov 2002 |
Giardiasis | CN | - | 26 Nov 2002 |
Leishmaniasis, Cutaneous | CN | - | 26 Nov 2002 |
Trichomonas Vaginitis | CN | - | 26 Nov 2002 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Gastrointestinal motility disorder | Phase 1 | CH | - |
Phase 2 | 30 | (Intravenous Antibacterial Agent) | bwrvfgrssq(zhipehbwah) = pwsmisxwil hsbtrqrofg (yzrwftcars, eqeyiojehm - wqyrlpyjyc) View more | - | 08 Jun 2018 | ||
(Oral Antibacterial Agent) | bwrvfgrssq(zhipehbwah) = mmolwkcnjq hsbtrqrofg (yzrwftcars, yjnrkzwdmu - hvugaqegfr) View more |